Application of glucocorticoids in patients with novel coronavirus infection: From bench to bedside
L Lu, J Huang, X Deng, X Sun, J Dong - Traditional Medicine and …, 2020 - World Scientific
Glucocorticoids (GCs) have potential anti-inflammatory and immunosuppressive effects.
There is plenty of controversy about the application of glucocorticoids in the treatment of …
There is plenty of controversy about the application of glucocorticoids in the treatment of …
Glucocorticoids and COVID-19
S Bruscoli, PG Puzzovio, M Zaimi, K Tiligada… - Pharmacological …, 2022 - Elsevier
Abstract Coronavirus Disease 19 (COVID-19) is associated with high morbidity and mortality
rates globally, representing the greatest health and economic challenge today. Several …
rates globally, representing the greatest health and economic challenge today. Several …
[HTML][HTML] The Role of Glucocorticoids in the Management of COVID-19
VI Alexaki, H Henneicke - Hormone and Metabolic Research, 2021 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), caused by an infection with the novel coronavirus
SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health …
SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health …
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
Prolonged, low-dose glucocorticoids (GCs) have shown the highest efficacy among
pharmacological and non-pharmacological treatments for COVID-19. Despite the World …
pharmacological and non-pharmacological treatments for COVID-19. Despite the World …
Perspectives on glucocorticoid treatment for COVID-19: a systematic review
LP Cordeiro, EONN Linhares, FGO Nogueira… - Pharmacological …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a viral pneumonia that can lead to acute
respiratory distress syndrome (ARDS). Until the commercialization of a vaccine …
respiratory distress syndrome (ARDS). Until the commercialization of a vaccine …
Glucocorticoids in COVID19; a friend not foe
BACKGROUND COVID19 is an emerging pandemic outbreak that is changing our life
causing a big challenge worldwide.[1] A major concern is being the virus highly and rapidly …
causing a big challenge worldwide.[1] A major concern is being the virus highly and rapidly …
[HTML][HTML] Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis
Background Glucocorticoids are widely used in the treatment of various pulmonary
inflammatory diseases, but they are also often accompanied by significant adverse …
inflammatory diseases, but they are also often accompanied by significant adverse …
New insights on effects of glucocorticoids in patients with SARS-CoV-2 infection
EC Shacham, A Ishay - Endocrine Practice, 2022 - Elsevier
Abstract Objective Since January 2020, the highly contagious novel coronavirus SARS-CoV-
2 has caused a global pandemic. Severe COVID-19 leads to a massive release of …
2 has caused a global pandemic. Severe COVID-19 leads to a massive release of …
Glucocorticoid therapy in COVID-19
F Amati, A Tonutti, J Huston… - Seminars in respiratory …, 2023 - thieme-connect.com
Coronavirus disease 2019 (COVID-19) pneumonia caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has resulted in significant mortality in pandemic …
syndrome coronavirus 2 (SARS-CoV-2) has resulted in significant mortality in pandemic …
[PDF][PDF] Perspectives on Glucocorticoid treatment of COVID-19: a systematic
LP Cordeiro, EONN Linhares, FGO Nogueira… - scholar.archive.org
Abstract Coronavirus disease 2019 (COVID-19) is an on-going pandemic, this viral
pneumonia can lead to a severe acute respiratory syndrome (SARS). Until the …
pneumonia can lead to a severe acute respiratory syndrome (SARS). Until the …